Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study.

Greg Flaker, Michael Ezekowitz, Salim Yusuf, Lars Wallentin, Herbert Noack, Martina Brueckmann, Paul Reilly, Stefan H Hohnloser, Stuart Connolly

Journal: Journal of the American College of Cardiology 2012;59(9):854-5

PMID: 22361407

Free Full Text on Elsevier Science View on PubMed

Abstract

DOI: 10.1016/j.jacc.2011.10.896

Link outs

Free resources

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0735...

Medical:

https://medlineplus.gov/stroke.html

Subscription / membership required

Full Text Sources:

https://www.clinicalkey.com/content/playBy/pii?v=S...

MeSH Terms: Anticoagulants, Atrial Fibrillation, Benzimidazoles, Dabigatran, Dose-Response Relationship, Drug, Electrocardiography, Embolism, Female, Follow-Up Studies, Heart Rate, Humans, Male, Randomized Controlled Trials as Topic, Stroke, Tachycardia, Paroxysmal, Time Factors, Treatment Outcome, Warfarin, beta-Alanine

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

Sponsor

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.